Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by PLITheOneon Nov 22, 2021 4:15pm
136 Views
Post# 34154413

RE:RE:Do I hear $1.10's

RE:RE:Do I hear $1.10's

Nothing!

Not disclosed to investors at the time, all Prometic technology IP was given as collateral during an SALP financing. During the refinancing scam to screw investors and take control, Liminal left $10M of that financing on the books rather than also converting to equity in order for SALP to retain these IP's. All indicators of their agenda now on the immediate horizon. 

Liminal is under the full control of SALP, a Thomvest company set up in the cayman island to further remove Peter Thomson who owns it all. Follow the $$$. They are protecting this asset from retail investors when Liminal is deep sixed. Not many know this, nor the fact they are facing a large lawsuit because they haven't disclosed to shareholders. 

Liminal has systematically given away all potential. I say gave away because the deals that they had made were a far cry from the value we were all led to believe. They essentially paid Kedrion to take the PPPS and approved Ryplasim. Most likely a side hustle out of the public eye for the true value. Never forget the predator who owns this now! 

Seems PBI-4050 was the jewel they were after. This, like the other technology, was disruptive. Hell it appeared as if PBI-4050 not only slowed the progression of fibrosis but effectively reversed it. 

This technology, and it's analogues, are valuable. These delays in development are intentional, they do not intend to realize the full potential under Liminal, but after they deep six it. There's probably a buyer already lined up. 

<< Previous
Bullboard Posts
Next >>